The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1161-1169

  Subramaniam, Ram ^a   Roediger, Fred ^a   Jordan, Brad ^a   Mattson, Mark P ^a,b   Keller, Jeffrey N ^a   Waeg, Georg ^c   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Alzheimer's disease; Amyloid; Electron paramagnetic resonance; Hydroxynonenal; Lipid peroxidation; Protein alterations; Synaptosomal membranes

Indexed keywords

4 HYDROXYNONENAL; MEMBRANE PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; LIPID PEROXIDATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN SYNTHESIS INHIBITION; RAT; SENILE PLAQUE; STEM CELL; SYNAPTOSOME;

ANIMALIA; GERBILLINAE;

EID: 0030746621     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031161.x     Document Type: Article

References (52)

1. Bellary S. S., Anderson K. W., Arden W. A., and Butterfield D. A. (1995) Effect of lipopolysaccharide on the physical conformation of erythrocyte cytoskeletal proteins. Life Sci. 56, 91-98.
2. Buko V. U., Artsukevich A., Zavodnik I., Maltsev A., Sushko L., Zimmerman T., and Dianzani M. U. (1996) Interactions of malondialdehyde and 4-hydroxynonenal with rat liver plasma membranes and their effect on binding of prostaglandin E2 by specific receptors. Free Radic. Res. 25, 415-420.
3. Butterfield D. A. (1982) Spin labeling in disease. Biol. Magn. Reson. 4, 1-78.
4. Butterfield D. A. (1996) Alzheimer's disease: a disorder of oxidative stress. Alzheimer Dis. Rev. 1, 68-70.
5. Butterfield D. A. (1997a) Alzheimer's amyloid β-peptide and free radical oxidative stress, in Reactive Oxygen Species in Biological Systems: An Interdisciplinary Approach (Gilbert D. L. and Colton C. A., eds). Plenum Press, New York (in press).
6. Butterfield D. A. (1997b) β-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem. Res. Toxicol. 10, 495-506.
7. Butterfield D. A. and Stadtman E. R. (1997) Protein oxidation processes in aging brain, in The Aging Brain (Mattson M. P. and Geddes J. W., eds). JAI Press, Greenwich, Connecticut (in press).
8. Butterfield D. A., Hensley K., Harris M., Mattson M. P., and Carney J. M. (1994) β-Amyloid free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200, 710-715.
9. Butterfield D. A., Hensley K., Hall N. C., Subramaniam R., Howard B. J., Cole P., Yatin S., Lafontaine M., Harris M. E., Aksenov M., Aksenova M., and Carney J. M. (1996a) β-Amyloid-derived free radical oxidation: a fundamental process in Alzheimer's disease, in Molecular Models of Dementia (Wasco W. and Tanzi R. E., eds), pp. 145-167. Humana Press, Totowa, New Jersey.
10. 2+, nitroxide spin probes, and synaptosomal membrane proteins. Life Sci. 58, 217-228.
11. Butterfield D. A., Subramaniam R., Cole P. S., Yatin S., Hensley K., Hall N. C., and Carney J. M. (1997a) Electron paramagnetic resonance studies of amyloid β-peptide- and ischemia/reperfusion-associated oxygen free radicals and the membrane damage they cause: relevance to Alzheimer's disease and stroke, in Oxygen Radicals and the Disease Process (Thomas C. E. and Kalyanaraman B., eds), Harwood Academic Press, Reading, U.K. (in press).
12. Butterfield D. A., Howard B. J., Yatin S., Allen K. L., and Carney J. M. (1997b) Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-α-phenyl-nitrone. Proc. Natl. Acad. Sci. USA 94, 674-678.
13. Cohn J. A., Tsai L., Friguet B., and Szweda L. I. (1996) Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress. Arch. Biochem. Biophys. 328, 158-164.
14. Esterbauer H., Zollner H., and Schaur R. J. (1990) Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence and determination, in Membrane Lipid Oxidation, Vol. 1 (Vigo-Pelfrey C., ed), pp. 239-283. CRC Press, Boca Raton, Florida.
15. Esterbauer H., Schaur R. J., and Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
16. Frankel E. N. (1982) Volatile lipid oxidation products. Prog. Lipid Res. 22, 1-33.
17. Friguet B., Stadtman E. R., and Szweda L. I. (1994) Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J. Biol. Chem. 269, 21639-21643.
18. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., McConlogue S., Montoya-Zavalal M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., and Zhao J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717V β-amyloid precursor protein. Nature 373, 523-527.
19. Grosch W. (1987) Reactions of hydroperoxides - products of low molecular weight, in Autoxidation of Unsaturated Lipids (Chan H. W. S., ed), pp. 95-122. Academic Press, New York.
20. Hall N. C., Carney J. M., Cheng M. S., and Butterfield D. A. (1995a) Ischemia/reperfusion-induced changes in membrane proteins and lipids of gerbil neocortical synaptosomes. Neuroscience 64, 81-89.
21. Hall N. C., Carney J. M., Cheng M. S., and Butterfield D. A. (1995b) Prevention of ischemia/reperfusion-induced alterations in synaptosomal membrane-associated proteins and lipids by N-tertbutyl-α-phenylnitrone and difluoromethylornithine. Neuroscience 69, 591-600.
22. Hall N. C., Dempsey R. J., Carney J. M., Donaldson D. L., and Butterfield D. A. (1995c) Structural alterations in synaptosomal membrane-associated proteins and lipids by transient middle cerebral artery occlusion in the cat. Neurochem. Res. 20, 1161-1169.
23. Hall N. C., Carney J. M., Plante O. J., Cheng M., and Butterfield D. A. (1997) Effect of 2-cyclohexene-1-one-induced glutathione diminution on ischemia/reperfusion-induced alterations in the physical state of brain synaptosomal membrane proteins and lipids. Neuroscience 77, 283-290.
24. Harris M., Hensley K., Butterfield D. A., Leedle R. A., and Carney J. M. (1995) Direct evidence of oxidative injury produced by the Alzheimer's β-amyloid peptide (1-40). Exp. Neurol. 131, 193-202.
25. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 67, 277-286.
26. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., and Butterfield D. A. (1994a) A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
27. Hensley K., Carney J. M., Hall N. C., Shaw W., and Butterfield D. A. (1994b) Electron paramagnetic resonance investigations of free radical induced alterations in neocortical synaptosomal membrane protein infrastructure. Free Radic. Biol. Med. 17, 321-333.
28. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Lovell M., Markesbery W. R., and Butterfield D. A. (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65, 2146-2156.
29. Hensley K., Butterfield D. A., Hall N. C., Cole P., Subramaniam R., Mark R., Mattson M. P., Markesbery W. R., Harris M. E., Aksenov M., Aksenova M., Wu J. F., and Carney J. M. (1996) Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid β-peptide. Ann. NY Acad. Sci. 786, 120-134.
30. Howard B. J., Yatin S., Hensley K., Allen K. L., Kelly J. P., Carney J. M., and Butterfield D. A. (1996) Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-α-phenylnitrone and 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol). J. Neurochem. 67, 2045-2050.
31. Keller J. N., Mark R. J., Bruce A. J., Blanc E. M., Rothstein J. D., Uchida K., and Mattson M. P. (1997) 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience (in press).
32. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
33. 2+ homeostasis and cell death. J. Neurosci. 15, 6239-6249.
34. Mark R. J., Blanc E. M., and Mattson M. P. (1996) Amyloid β-peptide and oxidative cell injury in Alzheimer's disease. Mol. Neurobiol. 12, 211-224.
35. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., and Mattson M. P. (1997) Evidence that 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death by amyloid-β peptide. J. Neurochem. 68, 255-264.
36. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-414.
37. Mattson M. P., Furukawa K., Bruce A. J., Mark R. J., and Blanc E. M. (1996) Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia, in Molecular Models of Dementia (Wasco W. and Tanzi R. E., eds), pp. 103-143. Humana Press, Totowa, New Jersey.
38. Montine T. J., Amarnath V., Martin M. E., Strittmatter W. J., and Graham D. G. (1996) E-4-Hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am. J. Pathol. 148, 89-93.
39. Nadkarni D. V. and Sayre L. M. (1995) Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8, 284-291.
40. Rohn T. T., Hinds T. R., and Vincenzi F. F. (1993) Ion transport ATPases as targets for free radical damage. Chem. Pharmacol. 46, 525-534.
41. Sayre L. M., Arora P. K., Iyer R. S., and Salomon R. G. (1993) Pyrrole formation from 4-hydroxynonenal and primary amines. Chem. Res. Toxicol. 6, 19-22.
42. Selkoe D. J. (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295-18298.
43. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
44. Subramaniam R., Howard B. J., Hensley K., Aksenova M., and Carney J. M. (1995) β-Amyloid (32-35) toxicity to biomolecules: implications to Alzheimer's disease. Alzheimer's Res. 1, 141-144.
45. Tomiyama T., Shoji A., Kattoka K. L., Suwa Y., Asano S., Kaneko H., and Endo N. (1996) Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. J. Biol. Chem. 271, 6839-6844.
46. Trad C. H. and Butterfield D. A. (1994) Menadione induced cytotoxicity effects on human erythrocyte membranes studied by electron paramagnetic resonance. Toxicol. Lett. 73, 145-155.
47. Uchida K., Osawa T., Hiai H., and Toyokuni S. (1995) 4-Hydroxy-2-nonenal-trapping ELISA: direct evidence for the release of a cytotoxic aldehyde from oxidized low density lipoproteins. Biochem. Biophys. Res. Commun. 33, 12487-12494.
48. Volterra A., Trotti D., Tromba C., Floridi S., and Racagni G. (1994) Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14, 2924-2932.
49. Waeg G., Dimsity G., and Esterbauer H. (1996) Monoclonal antibodies for detection of 4-hydroxy-modified proteins. Free Radic. Res. 25, 149-159.
50. Wyse J. W. and Butterfield D. A. (1988) Electron spin resonance and biochemical studies of the interaction of the polyamine, spermine, with the skeletal network of proteins in human erythrocyte membranes. Biochim. Biophys. Acta 941, 141-149.
51. Wyse J. W., Barker R., Franco R. S., Martelo O., and Butterfield D. A. (1987) Electron spin resonance (ESR) studies of skeletal protein interactions in human erythrocyte membranes exposed to polyanions and in membranes prepared from inositol hexaphosphate (IHP)-incorporated low-affinity erythrocytes. Biochem. Biophys. Res. Commun. 144, 779-786.
52. Yankner B. A., Duffy L. K., and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279-282.